1252 completed, 462 unknown, 282 recruiting, 248 terminated. 2535 Phase 3, 405 Phase 2.
Follow Gastrointestinal Diseases: new trials by email Literature Review of Gastrointestinal Diseases trials Research Report on Gastrointestinal Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Methadone as an Alternative Treatment for Children Underdoing HSCT PCA plus methadone (Experimental), PCA Alone (SOC) - Leukemia, Aplastic Anemia | Phase 3 | Suspended | University of Texas Southwestern Medical Center | 60 | 2028-01-01 | 2025-10-23 |
| Combination of Osemitamab (TST001), Pembrolizumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma Pembrolizumab and either Capcecitabine + Oxaliplatin or Oxaliplatin+Leucovorin + 5-fluorouracil - Gastric Cancer, Gastroesophageal-junction Cancer | Phase 3 | Not yet recruiting | Transcenta Therapeutics (Hangzhou) Co., Ltd. | 820 | 2027-06-30 | 2026-09-29 |
| Piperacillin/Tazobactam Versus Ceftriaxone and Metronidazole for Children With Perforated Appendicitis Piperacillin/Tazobactam, Ceftriaxone + Metronidazole - Appendicitis Perforated, Appendectomy, Laparoscopic | Phase 3 | Not yet recruiting | McMaster Children's Hospital | 180 | 2027-04-01 | 2026-10-09 |
| A Trial of ONO-4578 Versus Placebo in Combination With Nivolumab and Chemotherapy in Participants With Gastric Cancer, Esophagogastric Junction Cancer, or Esophageal Adenocarcinoma ONO-4578, Placebo, Nivolumab - Gastric Cancer, Esophagogastric Junction Cancer | Phase 3 | Not yet recruiting | Ono Pharmaceutical Co., Ltd. | 600 | 2027-02-01 | 2026-09-14 |
| Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial Bevacizumab, Biopsy Procedure, Biospecimen Collection - Metastatic Appendix Carcinoma, Metastatic Colorectal Carcinoma | Phase 3 | Recruiting | City of Hope Medical Center | 129 | 2027-01-04 | 2026-11-05 |
| Circulating Tumor DNA MRD-Guided Adjuvant Therapy for Curatively Resected Locally Advanced Esophageal Squamous Cell Carcinoma Tislelizumab - Esophageal Cancer | Phase 3 | Not yet recruiting | Asan Medical Center | 172 | 2026-12-31 | 2026-10-29 |
| Nitazoxanide for Treatment of Cryptosporidium in Children Nitazoxanide, Placebo - Cryptosporidiosis | Phase 3 | Not yet recruiting | Johns Hopkins Bloomberg School of Public Health | 480 | 2026-12-30 | 2026-09-28 |
| A Randomized, Controlled, Double-Blind, Multicenter Phase III Clinical Trial to Evaluate the Efficacy and Safety of Enlonstobart, With or Without SYS6010 as Adjuvant Therapy, in Participants With Pathologically Residual Esophageal Squamous Cell Carcinoma Following Complete Surgical Resection SYS6010, SG001, SG001 placebo-mimicking - Esophageal Squamous Cell Carcinoma | Phase 3 | Not yet recruiting | CSPC Megalith Biopharmaceutical Co.,Ltd. | 585 | 2026-12-30 | 2026-11-09 |
| Clinical Efficacy of Adebrelimab With or Without Apatinib Mesilate and SOX Neoadjuvant Therapy in Locally Advanced Gastric Cancer Apatinib Mesylate Tablets - Gastric Cancer, Surgery | Phase 3 | Not yet recruiting | Fujian Medical University | 118 | 2026-12-25 | 2026-01-02 |
| Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease Zanzalintinib, Pembrolizumab (+) Berahyaluronidase alfa, Placebo - Colorectal Cancer | Phase 3 | Recruiting | Exelixis | 600 | 2026-12-18 | 2026-11-12 |
| A Study of the Duration of Dostarlimab in Untreated Mismatch Repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) Locally Advanced Rectal Cancer Dostarlimab - Neoplasms, Rectal | Phase 3 | Not yet recruiting | GlaxoSmithKline | 100 | 2026-12-17 | 2026-11-16 |
| Radical Surgery Versus Non-Surgery in Gastric Cancer Patients With Peritoneal Metastasis After Successful Conversion Therapy Radical Gastrectomy with D2 Lymphadenectomy, Standard Systemic Therapy for Advanced Gastric Cancer - Gastric Cancer, Peritoneal Metastasis | Phase 3 | Recruiting | Hua Huang, MD, PhD | 170 | 2026-12-01 | 2026-10-16 |
| Rifaximin Treatment in Bloating Predominant Functional Bowel Disorders Rifaximin (drug), Placebo - Bloating, Rifaximin | Phase 3 | Not yet recruiting | Mahidol University | 78 | 2026-12-01 | 2026-10-27 |
| Effects of Butyrate Enemas on Postoperative Intestinal Motility Disorders in Hirschsprung's Disease Sodium Butyrate, routine management - Hirschsprung's Disease | Phase 3 | Not yet recruiting | Assistance Publique Hopitaux De Marseille | 58 | 2026-11-01 | 2026-09-10 |
| GFH375 Plus Cetuximab vs Investigator's Choice of Treatment in KRAS G12D-Mutant Refractory Metastatic Colorectal Cancer GFH375 + Cetuximab, Fruquintinib, Trifluridine and Tipiracil - Colorectal Cancer | Phase 3 | Not yet recruiting | Genfleet Therapeutics (Shanghai) Inc. | 368 | 2026-11-01 | 2026-11-03 |
| Master Protocol for the Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or mNSCLC Rilogrotug, Placebo - Cachexia; Cancer, Cachexia | Phase 2 / Phase 3 | Not yet recruiting | AVEO Pharmaceuticals, Inc. | 950 | 2026-11-01 | 2026-10-28 |
| Modified Short-Course Radiotherapy Combined With Tislelizumab and CAPOX for pMMR/MSS Rectal Cancer node-sparing modified short-course radiotherapy, standard short-course radiotherapy - Rectal Cancer | Phase 3 | Not yet recruiting | Sir Run Run Shaw Hospital | 210 | 2026-10-25 | 2026-10-28 |
| Nitazoxanide as Adjunct Therapy in Mild-to-Moderate Ulcerative Colitis Nitazoxanide (NTZ) - Ulcerative Colitis (UC) | Phase 2 / Phase 3 | Recruiting | Tanta University | 44 | 2026-10-25 | 2026-11-09 |
| Chemotherapy Combined With or Without Short-Course Radiotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for High-Risk Locally Advanced Colon Cancer With pMMR/MSS short-course radiotherapy, Serplulimab, CapOx(Capecitabine+ Oxaliplatin) - Locally Advanced Colon Cancer, pMMR | Phase 3 | Not yet recruiting | Fudan University | 480 | 2026-10-15 | 2026-10-16 |
| Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric Ulcer DWP14012 40mg (Fexuprazan), Lansoprazole 30mg - Gastric Ulcer | Phase 3 | Not yet recruiting | Daewoong Pharmaceutical Co. LTD. | 384 | 2026-10-15 | 2026-07-28 |
Showing 20 of 2535. Sign in to see all of them.
Colorectal Neoplasms (522) · Stomach Neoplasms (301) · Rectal Neoplasms (246) · Crohn Disease (238) · Colonic Neoplasms (237) · Colitis, Ulcerative (223) · Esophageal Neoplasms (133) · Gastroesophageal Reflux (116) · Inflammatory Bowel Diseases (97) · Esophageal Squamous Cell Carcinoma (80) · Irritable Bowel Syndrome (71) · Neoplasm Metastasis (70) · Neoplasms (63) · Gastroenteritis (47)
Digestive System Diseases (2506) · Intestinal Diseases (1609) · Digestive System Neoplasms (1322) · Neoplasms (1309) · Neoplasms by Site (1309) · Gastrointestinal Neoplasms (1296) · Colonic Diseases (970) · Intestinal Neoplasms (801) · Rectal Diseases (737) · Gastroenteritis (630) · Pathological Conditions, Signs and Symptoms (478) · Esophageal Diseases (412) · Stomach Diseases (407) · Inflammatory Bowel Diseases (363)
Fluorouracil (263) · Oxaliplatin (228) · Leucovorin (199) · Capecitabine (183) · Irinotecan (123) · Bevacizumab (115) · Cisplatin (97) · Radiotherapy (68) · Cetuximab (63) · Paclitaxel (61) · Mesalamine (59) · Folfox protocol (55) · Esomeprazole (49) · Drug Therapy (47) · Docetaxel (44)
Takeda (56) · AstraZeneca (49) · Sun Yat-sen University (49) · Fudan University (45) · Merck Sharp & Dohme LLC (33) · Hoffmann-La Roche (31) · Shire (31) · Janssen Research & Development, LLC (29) · AbbVie (28) · Chinese University of Hong Kong (26) · Alliance for Clinical Trials in Oncology (25) · National Cancer Institute (NCI) (24) · Bausch Health Americas, Inc. (21) · Assistance Publique - Hôpitaux de Paris (20) · Pfizer (20)
United States (765) · China (580) · France (433) · Germany (413) · Canada (411) · Italy (367) · United Kingdom (354) · South Korea (343) · Belgium (333) · Spain (330) · Poland (320) · Japan (292) · Netherlands (269) · Australia (265) · Hungary (220)
PMID 36306483, PMID 29380251, PMID 32445184, PMID 19735233, PMID 31268130, PMID 33356421, PMID 37368103, PMID 40341124, PMID 40357993, PMID 21129076, PMID 30679026, PMID 31378656, PMID 20195905, PMID 20526599, PMID 21997132, PMID 26893500, PMID 29850873, PMID 30476584, PMID 31077827, PMID 31599001, PMID 32085892, PMID 32635680, PMID 32766762, PMID 32816215, PMID 32870265, PMID 32964215, PMID 33324993, PMID 33684552, PMID 34614208, PMID 35648151, PMID 35792493, PMID 36124702, PMID 36208720, PMID 36336750, PMID 36342120, PMID 36526796, PMID 36931693, PMID 37310167, PMID 37402275, PMID 37560161, PMID 38096402, PMID 38310565, PMID 38425446, PMID 40013523, PMID 41264726, PMID 41763462, PMID 23451835, PMID 24118079, PMID 25996351, PMID 26049686
2023 (50), 2017 (33), 2015 (28), 2025 (22), 2016 (21), 2018 (21), 2019 (18), 2014 (17), 2009 (12), 2008 (11), 2004 (10), U10CA031946 (9), 2005 (6), U10CA032102 (6), U10CA012027 (5)